PDS Biotechnology Corporation (PDSB)
Largest Insider Buys in Sector
PDSB Stock Price History Chart
PDSB Stock Performance
About PDS Biotechnology Corporation
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.
Insider Activity of PDS Biotechnology Corporation
Over the last 12 months, insiders at PDS Biotechnology Corporation have bought $0 and sold $0 worth of PDS Biotechnology Corporation stock.
On average, over the past 5 years, insiders at PDS Biotechnology Corporation have bought $238,313 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 3,100 shares for transaction amount of $27,860 was made by HILL MATTHEW C () on 2021‑12‑13.
List of Insider Buy and Sell Transactions, PDS Biotechnology Corporation
| 2021-12-13 | HILL MATTHEW C | 3,100 0.012% | $8.99 | $27,860 | -41.56% | |||
| 2021-06-16 | Bloomquist DeLyle W | 10,000 0.0456% | $9.88 | $98,778 | -4.17% | |||
| 2021-06-15 | Glover Steve C | 5,882 0.0235% | $8.50 | $49,997 | -2.50% | |||
| 2021-06-15 | Freitag Gregory Gene | 5,882 0.0235% | $8.50 | $49,997 | -2.50% | |||
| 2021-06-15 | VAN VOORHEES SETH | 17,647 0.0704% | $8.50 | $150,000 | -2.50% | |||
| 2021-06-15 | Ali-Jackson Kamil | 11,764 0.0469% | $8.50 | $99,994 | -2.50% | |||
| 2018-03-22 | Sale | Macdonald R. Loch | Chief Scientific Officer | 5,000 0.0161% | $16.41 | $82,050 | -94.86% | |
| 2018-03-21 | Sale | Macdonald R. Loch | Chief Scientific Officer | 5,000 0.0159% | $16.52 | $82,600 | -94.94% | |
| 2018-03-20 | Sale | Macdonald R. Loch | Chief Scientific Officer | 10,000 0.0322% | $16.47 | $164,700 | -94.85% | |
| 2018-03-19 | Sale | Macdonald R. Loch | Chief Scientific Officer | 5,000 0.0161% | $16.59 | $82,950 | -94.88% | |
| 2018-03-02 | Sale | Leuthner Brian A | President and CEO | 5,000 0.0159% | $15.08 | $75,400 | -94.24% | |
| 2018-03-01 | Sale | Leuthner Brian A | President and CEO | 5,000 0.0161% | $14.95 | $74,725 | -94.13% | |
| 2018-02-23 | Sale | Leuthner Brian A | President and CEO | 5,000 0.0158% | $15.37 | $76,850 | -94.34% | |
| 2018-02-22 | Sale | Macdonald R. Loch | Chief Scientific Officer | 5,000 0.0151% | $14.49 | $72,450 | -94.25% | |
| 2018-02-22 | Sale | Leuthner Brian A | President and CEO | 5,000 0.0161% | $15.42 | $77,100 | -94.25% | |
| 2018-02-21 | Sale | Macdonald R. Loch | Chief Scientific Officer | 10,000 0.0304% | $13.82 | $138,200 | -93.91% | |
| 2018-02-20 | Sale | Macdonald R. Loch | Chief Scientific Officer | 10,000 0.0323% | $13.79 | $137,850 | -93.48% | |
| 2018-02-02 | Sale | Leuthner Brian A | President and CEO | 5,000 0.0163% | $12.96 | $64,800 | -92.76% | |
| 2018-02-01 | Sale | Leuthner Brian A | President and CEO | 5,000 0.0159% | $13.05 | $65,250 | -92.97% | |
| 2018-01-03 | Sale | Leuthner Brian A | President and CEO | 5,000 0.0162% | $10.11 | $50,550 | -90.32% |
Insider Historical Profitability
| HEALY JAMES | director | 2852711 9.1704% | $3.04 | 2 | 0 | <0.0001% |
| Hove Anders D | director | 2021917 6.4997% | $3.04 | 1 | 0 | <0.0001% |
| BARER SOL J | director | 632810 2.0342% | $3.04 | 1 | 0 | <0.0001% |
| Macdonald R. Loch | Chief Scientific Officer | 570602 1.8343% | $3.04 | 0 | 7 | |
| Bloomquist DeLyle W | 193888 0.6233% | $3.04 | 1 | 0 | <0.0001% | |
| Einhorn Andrew J. | Chief Financial Officer | 81941 0.2634% | $3.04 | 1 | 0 | <0.0001% |
| Leuthner Brian A | President and CEO | 70236 0.2258% | $3.04 | 0 | 35 | |
| Glover Steve C | 63790 0.2051% | $3.04 | 1 | 0 | <0.0001% | |
| Freitag Gregory Gene | 46153 0.1484% | $3.04 | 1 | 0 | <0.0001% | |
| Spiegel Robert J. | director | 37112 0.1193% | $3.04 | 1 | 0 | <0.0001% |
| VAN VOORHEES SETH | 17647 0.0567% | $3.04 | 1 | 0 | <0.0001% | |
| Ali-Jackson Kamil | 11764 0.0378% | $3.04 | 1 | 0 | <0.0001% | |
| MIDDLEKAUFF W BRADFORD | Senior VP, GC and Secretary | 10000 0.0321% | $3.04 | 2 | 0 | +8.46% |
| LOUGHLIN JAMES J | director | 6000 0.0193% | $3.04 | 3 | 0 | 0% |
| HILL MATTHEW C | 4075 0.0131% | $3.04 | 1 | 0 | <0.0001% | |
| Faleck Herbert J | Chief Medical Officer | 500 0.0016% | $3.04 | 1 | 0 | <0.0001% |
| Vaish Renu | V.P., Global Reg. Affairs | 350 0.0011% | $3.04 | 1 | 0 | <0.0001% |
| MARCHIO ALBERT N II | Chief Accounting & Adm Officer | 0 0% | $3.04 | 1 | 3 | <0.0001% |
Institutional Investor Ownership
| BlackRock | $7.4M | 5.09 | 1.87M | -0.74% | -$55,483.56 | <0.0001 | |
| The Vanguard Group | $6.29M | 4.33 | 1.59M | +5.46% | +$325,254.56 | <0.0001 | |
| Geode Capital Management | $2.59M | 1.78 | 654,185 | +3.31% | +$83,094.84 | <0.0001 | |
| State Street | $2.21M | 1.52 | 557,320 | +0.96% | +$20,940.48 | <0.0001 | |
| Inspirion Wealth Advisors LLC | $1.41M | 0.97 | 354,977 | +5.46% | +$72,796.68 | 0.25 | |
| Renaissance Technologies | $1.41M | 0.97 | 354,800 | +193.95% | +$927,030.72 | <0.01 | |
| Northern Trust | $955,274.00 | 0.66 | 241,231 | -3.39% | -$33,497.61 | <0.0001 | |
| Susquehanna International Group | $749,097.00 | 0.52 | 189,166 | -27.58% | -$285,325.78 | <0.01 | |
| Sofinnova | $564,835.00 | 0.39 | 142,635 | 0% | +$0 | <0.01 | |
| LINSCO PRIVATE LEDGER CORP | $508,721.00 | 0.35 | 128,465 | -2.33% | -$12,125.51 | <0.0001 | |
| Nuveen | $436,772.00 | 0.3 | 110,296 | +4.84% | +$20,176.19 | <0.0001 | |
| BNY Mellon | $391,446.00 | 0.27 | 98,850 | -8.25% | -$35,212.32 | <0.0001 | |
| Goldman Sachs | $358,277.00 | 0.25 | 90,474 | +624.6% | +$308,832.45 | <0.0001 | |
| Bank of America | $326,394.00 | 0.23 | 82,423 | -2.98% | -$10,014.81 | <0.0001 | |
| Charles Schwab | $305,724.00 | 0.21 | 77,203 | 0% | +$0 | <0.0001 | |
| Amussen Hunsaker Associates Llc | $294,835.00 | 0.21 | 75,016 | 0% | +$0 | 0.05 | |
| Jane Street Capital | $298,104.00 | 0.21 | 75,279 | +269.7% | +$217,470.71 | <0.0001 | |
| Morgan Stanley | $288,172.00 | 0.2 | 72,771 | -14.53% | -$49,004.80 | <0.0001 | |
| Xtx Topco Ltd | $238,606.00 | 0.16 | 60,254 | New | +$238,606.00 | 0.01 | |
| Citadel Advisors LLC | $203,405.00 | 0.14 | 51,365 | -60.6% | -$312,906.71 | <0.0001 | |
| UBS | $169,833.00 | 0.12 | 42,887 | +171.21% | +$107,213.34 | <0.0001 | |
| Marshall Wace | $163,235.00 | 0.11 | 41,221 | New | +$163,235.00 | <0.0001 | |
| Blair William Co Il | $158,400.00 | 0.11 | 40,000 | New | +$158,400.00 | <0.0001 | |
| Dimensional Fund Advisors | $156,978.00 | 0.11 | 39,641 | -5.98% | -$9,991.06 | <0.0001 | |
| AllianceBernstein | $149,846.00 | 0.1 | 37,840 | 0% | +$0 | <0.0001 | |
| RhumbLine Advisers | $138,576.00 | 0.1 | 34,996 | +3.55% | +$4,755.68 | <0.0001 | |
| Vontobel Holding Ltd | $126,720.00 | 0.09 | 32,000 | -21.95% | -$35,640.00 | <0.01 | |
| Group One Trading | $120,606.00 | 0.08 | 30,456 | -42.69% | -$89,836.74 | <0.01 | |
| Wolverine Trading | $117,224.00 | 0.08 | 29,602 | New | +$117,224.00 | <0.01 | |
| Simplex Trading Llc | $85,000.00 | 0.06 | 21,653 | -13.68% | -$13,464.65 | <0.01 | |
| AQR Capital | $82,590.00 | 0.06 | 20,856 | -28.73% | -$33,299.74 | <0.0001 | |
| Barclays | $78,000.00 | 0.05 | 19,766 | -48.53% | -$73,540.83 | <0.0001 | |
| Invesco | $73,374.00 | 0.05 | 18,529 | +1.53% | +$1,108.79 | <0.0001 | |
| T. Rowe Price | $70,000.00 | 0.05 | 17,539 | +11.34% | +$7,128.11 | <0.0001 | |
| Rathbone Brothers | $62,568.00 | 0.04 | 15,800 | +5.33% | +$3,168.00 | <0.0001 | |
| Deutsche Bank | $61,016.00 | 0.04 | 15,408 | -28.39% | -$24,187.81 | <0.0001 | |
| MetLife Investment Management | $59,503.00 | 0.04 | 15,026 | +0.66% | +$388.08 | <0.0001 | |
| American International Group | $55,250.00 | 0.04 | 13,952 | +0.38% | +$209.88 | <0.0001 | |
| Raymond James Associates | $54,854.00 | 0.04 | 13,852 | -43.14% | -$41,615.70 | <0.0001 | |
| Mercer Global Advisors Inc Adv | $50,000.00 | 0.03 | 12,500 | 0% | +$0 | <0.0001 | |
| The Manufacturers Life Insurance Company | $48,051.00 | 0.03 | 12,134 | 0% | +$0 | <0.0001 | |
| JPMorgan Chase | $46,814.00 | 0.03 | 11,822 | -41.11% | -$32,681.10 | <0.0001 | |
| Wells Fargo | $41,536.00 | 0.03 | 10,489 | +44.38% | +$12,766.91 | <0.0001 | |
| EP Wealth Advisors | $40,420.00 | 0.03 | 10,207 | 0% | +$0 | <0.01 | |
| Gsa Capital Partners Llp | $41,000.00 | 0.03 | 10,358 | New | +$41,000.00 | <0.01 | |
| Kathleen S Wright Associates Inc | $27,720.00 | 0.02 | 7,000 | New | +$27,720.00 | <0.01 | |
| Advisor Group Holdings Inc | $20,790.00 | 0.01 | 5,250 | +2,000% | +$19,800.00 | <0.0001 | |
| Citigroup | $18,945.00 | 0.01 | 4,784 | +19.18% | +$3,049.26 | <0.0001 | |
| Tower Research Capital | $16,446.00 | 0.01 | 4,153 | -54.09% | -$19,376.42 | <0.0001 | |
| Legal & General | $11,833.00 | 0.01 | 2,988 | 0% | +$0 | <0.0001 |